SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001411685-24-000022
Filing Date
2024-06-11
Accepted
2024-06-11 16:27:09
Documents
82
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-K vtgn-20240331.htm   iXBRL 10-K 1767580
2 EX-4.31 vtgn-exx431.htm EX-4.31 13201
3 EX-10.163 vtgn-20230810xexx10163.htm EX-10.163 61229
4 EX-23.1 vtgn-exx231x20240611.htm EX-23.1 2030
5 EX-31.1 vtgn-20230331xexx311.htm EX-31.1 9730
6 EX-31.2 vtgn-20230331xexx312.htm EX-31.2 10739
7 EX-32.1 vtgn-20230331xexx321.htm EX-32.1 4935
8 EX-97.1 vtgn-20231002xexx971.htm EX-97.1 34853
14 vtgn-20240331_g1.jpg GRAPHIC 126530
  Complete submission text file 0001411685-24-000022.txt   7502780

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtgn-20240331.xsd EX-101.SCH 53138
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtgn-20240331_cal.xml EX-101.CAL 66051
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtgn-20240331_def.xml EX-101.DEF 215466
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtgn-20240331_lab.xml EX-101.LAB 674970
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtgn-20240331_pre.xml EX-101.PRE 447766
86 EXTRACTED XBRL INSTANCE DOCUMENT vtgn-20240331_htm.xml XML 641079
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-37761 | Film No.: 241036153
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)